The APAC antibody identification market is observing robust expansion, fueled by a rising prevalence of chronic conditions and a heightened focus on personalized healthcare. Significant investment in research and progression, particularly within countries like China, Japan, and East Korea, is accelerating the integration of advanced antibody identi